Clinical Trial Update: SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 2 study evaluating SU5416 in patients with metastatic or locally recurrent colorectal cancer. No r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED